机译:恶性中枢神经系统淋巴瘤中黏附分子和基质金属蛋白酶的免疫组织化学分析:比较原发性中枢神经系统恶性和中枢神经系统血管内淋巴瘤的研究
Department of Neurosurgery Osaka University Graduate School of Medicine 2-2 Yamadaoka Suita Osaka 565-0871 Japan;
Department of Neurosurgery Osaka University Graduate School of Medicine 2-2 Yamadaoka Suita Osaka 565-0871 Japan;
Department of Neurosurgery Osaka University Graduate School of Medicine 2-2 Yamadaoka Suita Osaka 565-0871 Japan;
Department of Neurosurgery Osaka University Graduate School of Medicine 2-2 Yamadaoka Suita Osaka 565-0871 Japan;
Department of Neurosurgery Osaka University Graduate School of Medicine 2-2 Yamadaoka Suita Osaka 565-0871 Japan;
Department of Neurosurgery Osaka University Graduate School of Medicine 2-2 Yamadaoka Suita Osaka 565-0871 Japan;
Department of Neurosurgery Osaka University Graduate School of Medicine 2-2 Yamadaoka Suita Osaka 565-0871 Japan;
Department of Neurosurgery Osaka University Graduate School of Medicine 2-2 Yamadaoka Suita Osaka 565-0871 Japan;
Primary central nervous system malignant lymphoma (PCNSML); Intravascular lymphoma (IVL); Tumor cell invasion;
机译:恶性中枢神经系统淋巴瘤中黏附分子和基质金属蛋白酶的免疫组织化学分析:比较原发性中枢神经系统恶性和中枢神经系统血管内淋巴瘤的研究
机译:伊布洛替尼单药治疗复发或难治性原发性CNS淋巴瘤(PCNSL)和主要玻璃体视网膜淋巴瘤(PVRL)。 ilya和法国LOC网络中ILOC期II研究中临时分析的结果
机译:原发性中枢神经系统弥漫性大B细胞淋巴瘤和血管内大B细胞淋巴瘤的比较临床病理研究。
机译:通过无标记的定量质谱法在脑脊髓液中分析人CNS淋巴瘤的低浓度生物标志物
机译:细胞外基质蛋白CCN1(Cyr61)负调控内皮细胞粘附分子。
机译:大剂量化学疗法和自体干细胞移植与常规化学疗法相比在新诊断的原发性中枢神经系统淋巴瘤中得以巩固—一项随机III期试验(MATRix)
机译:原发性中枢神经系统淋巴瘤患者使用甲氨蝶呤,阿糖胞苷,thiotepa和利妥昔单抗(maTRix方案)进行化学免疫治疗:国际结外淋巴瘤研究组-32(IELsG32)2期试验首次随机化的结果